Does Addition of a Vessel Loop in Wound Closure Improve Suture Removal?

NCT ID: NCT04339439

Last Updated: 2023-02-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

47 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-08-01

Study Completion Date

2022-07-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will investigate whether adding a vessel loop under sutures after elective carpal tunnel release increases patient satisfaction with suture removal.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Surgical wound closure with nonabsorbable stitches necessitates subsequent suture removal, a process that can be uncomfortable for the patient and consume clinic time and resources. Anecdotal evidence suggests that the addition of a vessel loop under the sutures both simplifies suture removal and reduces discomfort. In this study, we propose a prospective, randomized, controlled, superiority trial to assess the impact of a vessel loop wound closure and suture removal for elective carpal tunnel release (CTR). Patients will be prospectively enrolled to one of two groups: closure without a vessel loop or closure with a vessel loop. The primary outcome measure will be patient satisfaction with suture removal. Time for wound closure, time for suture removal, pain with suture removal and other patient reported outcomes will be measured. These data will allow us to determine the benefit of addition of a vessel loop in wound closure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patient Satisfaction Suture, Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients who agree to participate will be enrolled and randomized to one of two study groups:

* Group 1: Incision closure without a vessel loop.
* Group 2: Incision closure with a vessel loop.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Closure without vessel loop

These patients will receive standard of care closure of the carpal tunnel release incision.

Group Type NO_INTERVENTION

No interventions assigned to this group

Closure with vessel loop

These patients will receive closure of the carpal tunnel release incision with a vessel loop placed under the sutures.

Group Type EXPERIMENTAL

Vessel loop (FDA product code FZZ)

Intervention Type DEVICE

The intervention will be a vessel loop placed below sutures to raise the sutures from the skin of the palm.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vessel loop (FDA product code FZZ)

The intervention will be a vessel loop placed below sutures to raise the sutures from the skin of the palm.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing elective primary CTR (CPT 64721) at Carilion Clinic for carpal tunnel syndrome (CTS) diagnosed by CTS-6 or electrodiagnostic studies (EDS).

Exclusion Criteria

* Emergency procedures.
* Revision procedures.
* Bilateral procedures.
* Concomitant procedures.
* Inability to provide informed consent for the study.
* Non-native English speakers.
* Allergy to suture material.
* History of wrist trauma.
Minimum Eligible Age

18 Years

Maximum Eligible Age

79 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Carilion Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter J Apel, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Carilion Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Carilion Institute for Orthopaedics & Neurosciences

Roanoke, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-20-737

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Feasibility Study of a New Fistula Pouching System
NCT00294450 COMPLETED PHASE2/PHASE3
Suture Closure Trial
NCT05261425 ACTIVE_NOT_RECRUITING NA
DuraMesh Laparotomy Study
NCT03966768 WITHDRAWN NA